Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 204


Systematic reviews and randomised controlled trials on open angle glaucoma.

Wormald R, Virgili G, Azuara-Blanco A.

Eye (Lond). 2020 Jan;34(1):161-167. doi: 10.1038/s41433-019-0687-5. Epub 2019 Dec 3. Review.


Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.

Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, Ambler G, Bunce C, Wormald R, Nathwani N, Barton K, Rubin G, Morris S, Buszewicz M.

Health Technol Assess. 2019 Jun;23(31):1-102. doi: 10.3310/hta23310.


Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial.

Garg A, Vickerstaff V, Nathwani N, Garway-Heath D, Konstantakopoulou E, Ambler G, Bunce C, Wormald R, Barton K, Gazzard G; Laser in Glaucoma and Ocular Hypertension Trial Study Group.

Ophthalmology. 2019 Sep;126(9):1238-1248. doi: 10.1016/j.ophtha.2019.04.012. Epub 2019 Apr 25.


Cervical Sympathetic Chain Paraganglioma: A Rare Cause of Asymmetrical Tonsillar Enlargement.

Esmaili AA, Gilfillan M, Wormald RN.

Ear Nose Throat J. 2019 Apr 9:145561319841201. doi: 10.1177/0145561319841201. [Epub ahead of print] No abstract available.


Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.

Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, Ambler G, Bunce C, Wormald R, Nathwani N, Barton K, Rubin G, Buszewicz M; LiGHT Trial Study Group.

Lancet. 2019 Apr 13;393(10180):1505-1516. doi: 10.1016/S0140-6736(18)32213-X. Epub 2019 Mar 9. Erratum in: Lancet. 2019 Jul 6;394(10192):e1.


Analysis of a Systematic Review About Blue Light-Filtering Intraocular Lenses for Retinal Protection: Understanding the Limitations of the Evidence.

Downie LE, Wormald R, Evans J, Virgili G, Keller PR, Lawrenson JG, Li T.

JAMA Ophthalmol. 2019 Jun 1;137(6):694-697. doi: 10.1001/jamaophthalmol.2019.0019.


Cochrane Eyes and Vision: a perspective introducing Cochrane Corner in Eye.

Evans J, Li T, Virgili G, Wormald R; Cochrane Eyes and Vision.

Eye (Lond). 2019 Jun;33(6):882-886. doi: 10.1038/s41433-019-0357-7. Epub 2019 Feb 19. Review.


Improvement in lung function following medialisation thyroplasty in a postbilateral lung transplant patient.

Hendriks T, Wormald R.

BMJ Case Rep. 2018 Sep 5;2018. pii: bcr-2018-225998. doi: 10.1136/bcr-2018-225998.


Prevalence and Causes of Visual Loss Among the Indigenous Peoples of the World: A Systematic Review.

Foreman J, Keel S, van Wijngaarden P, Bourne RA, Wormald R, Crowston J, Taylor HR, Dirani M.

JAMA Ophthalmol. 2018 May 1;136(5):567-580. doi: 10.1001/jamaophthalmol.2018.0597.


Vision loss in Indigenous peoples of the world: a systematic review protocol.

Foreman J, Keel S, van Wijngaarden P, Bourne R, Wormald R, Crowston J, Taylor HR, Dirani M.

JBI Database System Rev Implement Rep. 2018 Feb;16(2):260-268. doi: 10.11124/JBISRIR-2017-003419.


Sight Impairment registration due to stroke-A small yet significant rise?

Bunce C, Zekite A, Wormald R, Rowe F.

Brain Behav. 2017 Oct 29;7(12):e00866. doi: 10.1002/brb3.866. eCollection 2017 Dec.


Risk of Intraocular Bleeding and the New Anticoagulants: Not Such a Big Effect.

Wormald R, Evans J.

JAMA Ophthalmol. 2017 Nov 1;135(11):1281. doi: 10.1001/jamaophthalmol.2017.4021. No abstract available.


Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodology.

Gazzard G, Konstantakopoulou E, Garway-Heath D, Barton K, Wormald R, Morris S, Hunter R, Rubin G, Buszewicz M, Ambler G, Bunce C; LiGHT Trial Study Group.

Br J Ophthalmol. 2018 May;102(5):593-598. doi: 10.1136/bjophthalmol-2017-310877. Epub 2017 Sep 13.


What Makes Systematic Reviews Systematic and Why are They the Highest Level of Evidence?

Wormald R, Evans J.

Ophthalmic Epidemiol. 2018 Feb;25(1):27-30. doi: 10.1080/09286586.2017.1337913. Epub 2017 Sep 11. No abstract available.


Cochrane Risk of Bias : 'Your common man has no conception of the zeal that animates a scientific investigator, the fury of contradiction you can arouse in him'.

Bunce C, Lawrenson JG, Wormald R, Virgili G.

Ophthalmic Physiol Opt. 2017 Sep;37(5):627-628. doi: 10.1111/opo.12394. No abstract available.


A Mixed-Methods Evaluation of a Community-Based Glaucoma Check Service in Hackney, London, UK.

Holdsworth E, Datta J, Marks D, Kuper H, Lee H, Leamon S, Lindfield R, Wormald R, Clarke J, Elkarmouty A, Macdowall W.

Ophthalmic Epidemiol. 2017 Aug;24(4):248-256. doi: 10.1080/09286586.2016.1272702. Epub 2017 Mar 13.


Missed opportunity from randomised controlled trials of medical interventions for open-angle glaucoma.

Law A, Lindsley K, Rouse B, Wormald R, Dickersin K, Li T.

Br J Ophthalmol. 2017 Oct;101(10):1315-1317. doi: 10.1136/bjophthalmol-2016-309695. Epub 2017 Mar 7. Review.


Improving services for glaucoma care in Nigeria: implications for policy and programmes to achieve universal health coverage.

Kyari F, Gilbert C, Blanchet K, Wormald R.

Br J Ophthalmol. 2017 May;101(5):543-547. doi: 10.1136/bjophthalmol-2016-310040. Epub 2017 Feb 15.


Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.

Lim BX, Lim CH, Lim DK, Evans JR, Bunce C, Wormald R.

Cochrane Database Syst Rev. 2016 Nov 1;11:CD006683. Review.



Li T, Lindsley K, Rouse B, Hong H, Shi Q, Friedman DS, Wormald R, Dickersin K.

Ophthalmology. 2016 Nov;123(11):e66. doi: 10.1016/j.ophtha.2016.03.041. No abstract available.


Ethnicity and Deprivation are Associated With Blindness Among Adults With Primary Glaucoma in Nigeria: Results From the Nigeria National Blindness and Visual Impairment Survey.

Kyari F, Wormald R, Murthy GV, Evans JR, Gilbert CE; Nigeria National Blindness and Visual Impairment Study Group.

J Glaucoma. 2016 Oct;25(10):e861-e872.


Ab interno trabecular bypass surgery with Trabectome for open angle glaucoma.

Hu K, Gazzard G, Bunce C, Wormald R.

Cochrane Database Syst Rev. 2016 Aug 15;(8):CD011693. doi: 10.1002/14651858.CD011693.pub2. Review.


Uveitis certifications.

Quartilho A, Simkiss P, Zekite A, Xing W, Wormald R, Bunce C.

Eye (Lond). 2016 Nov;30(11):1522. doi: 10.1038/eye.2016.121. Epub 2016 Jun 17. No abstract available.


Risk factors for open-angle glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey.

Kyari F, Abdull MM, Wormald R, Evans JR, Nolan W, Murthy GV, Gilbert CE; Nigeria National Blindness and Visual Impairment Study Group.

BMC Ophthalmol. 2016 Jun 7;16:78. doi: 10.1186/s12886-016-0264-7.


Geographical variation in glaucoma prescribing trends in England 2008-2012: an observational ecological study.

Heng JS, Wormald R, Khaw PT.

BMJ Open. 2016 May 17;6(5):e010429. doi: 10.1136/bmjopen-2015-010429.


Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013.

Quartilho A, Simkiss P, Zekite A, Xing W, Wormald R, Bunce C.

Eye (Lond). 2016 Apr;30(4):602-7. doi: 10.1038/eye.2015.288. Epub 2016 Jan 29.


The Royal College of Ophthalmologists' Cataract Surgery Commissioning Guidance: executive summary.

Day AC, Wormald R, Coronini-Cronberg S, Smith R; Royal College of Ophthalmologists Cataract Surgery Commissioning Guidance Development Group.

Eye (Lond). 2016 Mar;30(3):498-502. doi: 10.1038/eye.2015.271. Epub 2016 Jan 22. No abstract available.


A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey.

Kyari F, Entekume G, Rabiu M, Spry P, Wormald R, Nolan W, Murthy GV, Gilbert CE; Nigeria National Blindness and Visual Impairment Study Group.

BMC Ophthalmol. 2015 Dec 12;15:176. doi: 10.1186/s12886-015-0160-6.


Randomised, single-masked non-inferiority trial of femtosecond laser-assisted versus manual phacoemulsification cataract surgery for adults with visually significant cataract: the FACT trial protocol.

Day AC, Burr JM, Bunce C, Doré CJ, Sylvestre Y, Wormald RP, Round J, McCudden V, Rubin G, Wilkins MR; FACT Group.

BMJ Open. 2015 Nov 27;5(11):e010381. doi: 10.1136/bmjopen-2015-010381.


Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis.

Li T, Lindsley K, Rouse B, Hong H, Shi Q, Friedman DS, Wormald R, Dickersin K.

Ophthalmology. 2016 Jan;123(1):129-40. doi: 10.1016/j.ophtha.2015.09.005. Epub 2015 Oct 31. Review.


Latanoprost for glaucoma: primum non nocere - Authors' reply.

Garway-Heath DF, Bunce C, Broadway DC, Martin KR, Lascaratos G, Wormald RP.

Lancet. 2015 Aug 15;386(9994):652. doi: 10.1016/S0140-6736(15)61500-8. No abstract available.


Congenital nasal pyriform aperture stenosis 5.7 mm or less is associated with surgical intervention: A pooled case series.

Wormald R, Hinton-Bayre A, Bumbak P, Vijayasekaran S.

Int J Pediatr Otorhinolaryngol. 2015 Nov;79(11):1802-5. doi: 10.1016/j.ijporl.2015.07.026. Epub 2015 Jul 28. Review.


Considerations for randomizing 1 eye or 2 eyes.

Bunce C, Wormald R.

JAMA Ophthalmol. 2015 Oct;133(10):1221. doi: 10.1001/jamaophthalmol.2015.2757. No abstract available.


Certification figures and their accuracy.

Quartilho A, Zekite A, Xing W, Loutfi M, Bunce C, Wormald R.

Eye (Lond). 2015 Nov;29(11):1516. doi: 10.1038/eye.2015.143. Epub 2015 Jul 31. No abstract available.


Potential for a paradigm change in the detection of retinopathy of prematurity requiring treatment.

Gilbert C, Wormald R, Fielder A, Deorari A, Zepeda-Romero LC, Quinn G, Vinekar A, Zin A, Darlow B.

Arch Dis Child Fetal Neonatal Ed. 2016 Jan;101(1):F6-9. doi: 10.1136/archdischild-2015-308704. Epub 2015 Jul 24. No abstract available.


Incidence of Late-Stage Age-Related Macular Degeneration in American Whites: Systematic Review and Meta-analysis.

Rudnicka AR, Kapetanakis VV, Jarrar Z, Wathern AK, Wormald R, Fletcher AE, Cook DG, Owen CG.

Am J Ophthalmol. 2015 Jul;160(1):85-93.e3. doi: 10.1016/j.ajo.2015.04.003. Epub 2015 Apr 6. Review.


Nigeria normative data for defining glaucoma in prevalence surveys.

Kyari F, Abdull MM, Sallo FB, Spry PG, Wormald R, Peto T, Faal HB, Gilbert CE; Nigeria National Blindness and Visual Impairment Study Group.

Ophthalmic Epidemiol. 2015 Apr;22(2):98-108. doi: 10.3109/09286586.2015.1012268.


Preventing eye injuries in quarries.

Wormald R, Patel D.

Community Eye Health. 2015;28(91):53. No abstract available.


Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial.

Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, Azuara-Blanco A, Bourne RR, Broadway DC, Cunliffe IA, Diamond JP, Fraser SG, Ho TA, Martin KR, McNaught AI, Negi A, Patel K, Russell RA, Shah A, Spry PG, Suzuki K, White ET, Wormald RP, Xing W, Zeyen TG.

Lancet. 2015 Apr 4;385(9975):1295-304. doi: 10.1016/S0140-6736(14)62111-5. Epub 2014 Dec 19. Erratum in: Lancet. 2015 Jul 11;386(9989):136.


The Sight Loss and Vision Priority Setting Partnership (SLV-PSP): overview and results of the research prioritisation survey process.

Rowe F, Wormald R, Cable R, Acton M, Bonstein K, Bowen M, Bronze C, Bunce C, Conroy D, Cowan K, Evans K, Fenton M, Giles H, Gordon I, Halfhide L, Harper R, Lightstone A, Votruba M, Waterman H, Zekite A.

BMJ Open. 2014 Jul 23;4(7):e004905. doi: 10.1136/bmjopen-2014-004905.


5-Fluorouracil for glaucoma surgery.

Green E, Wilkins M, Bunce C, Wormald R.

Cochrane Database Syst Rev. 2014 Feb 19;(2):CD001132. doi: 10.1002/14651858.CD001132.pub2. Review.


Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma.

Eldaly MA, Bunce C, Elsheikha OZ, Wormald R.

Cochrane Database Syst Rev. 2014 Feb 15;(2):CD007059. doi: 10.1002/14651858.CD007059.pub2. Review.


Evidence-based ophthalmology.

Wormald R, Dickersin K; Cochrane Eyes and Vision Group.

Ophthalmology. 2013 Dec;120(12):2361-2363.e1. doi: 10.1016/j.ophtha.2013.08.032. No abstract available.


Causes of certifications for severe sight impairment (blind) and sight impairment (partial sight) in children in England and Wales.

Mitry D, Bunce C, Wormald R, Leamon S, Simkiss P, Cumberland P, Rahi J, Bowman R.

Br J Ophthalmol. 2013 Nov;97(11):1431-6. doi: 10.1136/bjophthalmol-2013-303578. Epub 2013 Sep 13.


The effectiveness of schemes that refine referrals between primary and secondary care--the UK experience with glaucoma referrals: the Health Innovation & Education Cluster (HIEC) Glaucoma Pathways Project.

Ratnarajan G, Newsom W, Vernon SA, Fenerty C, Henson D, Spencer F, Wang Y, Harper R, McNaught A, Collins L, Parker M, Lawrenson J, Hudson R, Khaw PT, Wormald R, Garway-Heath D, Bourne R.

BMJ Open. 2013 Jul 21;3(7). pii: e002715. doi: 10.1136/bmjopen-2013-002715. Print 2013.


The NHS Act of 1951; is it time to re-act?

Ratnarajan G, Wormald R, Astbury N.

Eye (Lond). 2013 Jun;27(6):685-7. doi: 10.1038/eye.2013.65. No abstract available.


Retinal dystrophy and primary angle-closure glaucoma.

Ziaei M, Khalili A, Wormald R.

Int Ophthalmol. 2013 Dec;33(6):737-9. doi: 10.1007/s10792-013-9771-1. Epub 2013 Apr 8. No abstract available.


The British Asian community eye study: outline of results on the prevalence of eye disease in British Asians with origins from the Indian subcontinent.

Rauf A, Malik R, Bunce C, Wormald R.

Indian J Ophthalmol. 2013 Feb;61(2):53-8. doi: 10.4103/0301-4738.107191.


Better value eye care for the 21st century: the population approach.

Malik AN, Cassels-Brown A, Wormald R, Gray JA.

Br J Ophthalmol. 2013 May;97(5):553-7. doi: 10.1136/bjophthalmol-2012-302067. Epub 2013 Jan 15.


Supplemental Content

Loading ...
Support Center